These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2365010)

  • 1. Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouse.
    Weihmuller FB; Bruno JP; Neff NH; Hadjiconstantinou M
    Eur J Pharmacol; 1990 May; 180(2-3):369-72. PubMed ID: 2365010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
    Fries DS; de Vries J; Hazelhoff B; Horn AS
    J Med Chem; 1986 Mar; 29(3):424-7. PubMed ID: 3485197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.
    Tanji H; Araki T; Nagasawa H; Itoyama Y
    Brain Res; 1999 Apr; 824(2):224-31. PubMed ID: 10196452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M; Mariani AP; Neff NH
    Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.
    Peroutka SJ; DeLanney L; Irwin I; Ison PJ; Ricaurte G; Schlegel JR; Langston JW
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):163-71. PubMed ID: 3875136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys.
    Falardeau P; Bédard PJ; Di Paolo T
    Neurosci Lett; 1988 Mar; 86(2):225-9. PubMed ID: 2966905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
    Janson AM; Agnati LF; Fuxe K; Cintra A; Sundstrom E; Zini I; Toffano G; Goldstein M
    Acta Physiol Scand; 1988 Apr; 132(4):587-8. PubMed ID: 3265839
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
    Beresford IJ; Davenport AP; Sirinathsinghji DJ; Hall MD; Hill RG; Hughes J
    Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
    Janson AM; Fuxe K; Sundström E; Agnati LF; Goldstein M
    Acta Physiol Scand; 1988 Apr; 132(4):589-91. PubMed ID: 3265840
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal dopamine receptors in C57BL/6 mice.
    Bhargava HN; Perlow MJ
    Toxicol Lett; 1988 Mar; 40(3):219-24. PubMed ID: 3258448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D1 receptor and dopamine D2 receptor binding activity changes during chronic administration of nicotine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Wiener HL; Lajtha A; Sershen H
    Neuropharmacology; 1989 May; 28(5):535-7. PubMed ID: 2657481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with GM1 ganglioside reverses dopamine D-2 receptor supersensitivity induced by the neurotoxin MPTP.
    Hadjiconstantinou M; Weihmuller F; Neff NH
    Eur J Pharmacol; 1989 Sep; 168(2):261-4. PubMed ID: 2532603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse.
    Ferraro TN; Golden GT; DeMattei M; Hare TA; Fariello RG
    Neuropharmacology; 1986 Sep; 25(9):1071-4. PubMed ID: 2430229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantial telomere shortening in the substantia nigra of telomerase-deficient mice does not increase susceptibility to MPTP-induced dopamine depletion.
    Oeckl P; Scheffold A; Lechel A; Rudolph KL; Ferger B
    Neuroreport; 2014 Mar; 25(5):335-9. PubMed ID: 24525820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
    Rai SN; Yadav SK; Singh D; Singh SP
    J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH 23390 enhances exogenous L-DOPA decarboxylation in nigrostriatal neurons.
    Neff NH; Wemlinger TA; Hadjiconstantinou M
    J Neural Transm (Vienna); 2000; 107(4):429-43. PubMed ID: 11215754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasticity of the nigrostriatal system in MPTP-treated mice. A biochemical and morphological correlation.
    Cruz-Sanchez FF; Cardozo A; Ambrosio S; Tolosa E; Mahy N
    Mol Chem Neuropathol; 1993; 19(1-2):163-76. PubMed ID: 8103334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice.
    Otto D; Unsicker K
    J Neurosci; 1990 Jun; 10(6):1912-21. PubMed ID: 1972393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
    Schneider JS; Kean A; DiStefano L
    J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.